Overview

Bioequivalence Study to Compare Ibuprofen/ Paracetamol Tablets (200mg Ibuprofen/ 500mg Paracetamol) Versus Nuromol® Tablets (200mg Ibuprofen/ 500mg Paracetamol)

Status:
Completed

Trial end date:
2023-10-16

Target enrollment:

Participant gender:

Summary

Randomized, two-way, two-period, single oral dose, open-label, crossover, bioequivalence study to compare Ibuprofen/ Paracetamol tablets (200mg Ibuprofen/ 500mg Paracetamol) versus Nuromol® tablets (200mg Ibuprofen/ 500mg Paracetamol) in healthy subjects under fasting condition.

Phase:

Phase 1

Details

Lead Sponsor:

Humanis Saglık Anonim Sirketi

Treatments:

Acetaminophen
Ibuprofen